Advertisement

Topics

Clinical trial examines drug combo as remission-inducing treatment options for LAM

20:00 EDT 6 Aug 2017 | AAAS

(University of Cincinnati Academic Health Center) Researchers at the University of Cincinnati begin a new clinical trial this fall, examining the potential role of a drug combination therapy to eliminate lymphangioleiomyomatosis (LAM) cells.

Original Article: Clinical trial examines drug combo as remission-inducing treatment options for LAM

NEXT ARTICLE

More From BioPortfolio on "Clinical trial examines drug combo as remission-inducing treatment options for LAM"

Quick Search
Advertisement
 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...